Prophesys was a large, prospective, international study that comprised three separate, non interventional cohorts rus according to country-specific legal and regulatory requirements. The primary objective of Prophesys was to investigate the predictive value of virological responses by weeks 2, 4, and 12 on SVR in a routine clinical practice setting.

Hepatitis C treatment outcomes and predictors of response in treatment-naive patients treated wit Peginterferon alfa/Ribavirin in real world Italian clinics compared with other countries: prophesys sub-analysis

CONTINI, Carlo
2013

Abstract

Prophesys was a large, prospective, international study that comprised three separate, non interventional cohorts rus according to country-specific legal and regulatory requirements. The primary objective of Prophesys was to investigate the predictive value of virological responses by weeks 2, 4, and 12 on SVR in a routine clinical practice setting.
2013
Hepatitis C; Peginterferon alfa/Ribavirin, Prophesys
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/1965212
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact